These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Oparil S; Yarows SA; Patel S; Fang H; Zhang J; Satlin A Lancet; 2007 Jul; 370(9583):221-229. PubMed ID: 17658393 [TBL] [Abstract][Full Text] [Related]
11. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats. Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314 [TBL] [Abstract][Full Text] [Related]
12. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan. Chrysant SG Drugs Today (Barc); 2010 Mar; 46(3):151-62. PubMed ID: 20467589 [TBL] [Abstract][Full Text] [Related]
13. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906 [TBL] [Abstract][Full Text] [Related]
14. The direct renin inhibitor aliskiren localizes and persists in rat kidneys. Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182 [TBL] [Abstract][Full Text] [Related]
15. Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice. Saraswat MS; Addepalli V; Jain M; Pawar VD; Patel RB Pharmacol Rep; 2014 Feb; 66(1):62-7. PubMed ID: 24905308 [TBL] [Abstract][Full Text] [Related]